Non-Hodgkin Lymphoma - Observational Epidemiological and Clinical Study (NiHiL)
Trial Parameters
Brief Summary
The Czech National Lymphoma Registry (NiHiL) was founded to monitor epidemiologic data and improve the diagnostic evaluation and quality of treatment of patients with non-Hodgkin´s lymphoma (NHL). The patients are registered into the registry in anonymized form. For each patient are available: registration form, diagnostic form, treatment form, follow- up form, and other malignancy form. Data quality in the NiHiL has been checked by audits. The data is analyzed according to NHL subtypes with endpoints: lymphoma distribution, epidemiological data, prognostic characteristic, treatment characteristics, response rate, relapse rate, mortality, PFS, OS, DFS, Lymphoma specific survival, longterm toxicity.
Eligibility Criteria
Inclusion Criteria: * lymphoma diagnosis * treated in the Czech Republic * signed informed consent Exclusion Criteria: * unsigned informed consent * age \<18 y